Phase Ⅲ study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced nonsmall-cell lung cancer .A randomized,doubleblind,placebo-controlled,phase Ⅲ b trial(ATLAS)comparing bevacizumab(B)therapy ......